Bristol John W & CO Inc Novartis Ag Transaction History
Bristol John W & CO Inc
- $5.55 Billion
- Q1 2025
A detailed history of Bristol John W & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Bristol John W & CO Inc holds 593,726 shares of NVS stock, worth $66.4 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
593,726
Previous 609,682
2.62%
Holding current value
$66.4 Million
Previous $59.3 Million
11.56%
% of portfolio
1.19%
Previous 1.05%
Shares
35 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.32 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.16 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$963 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$789 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$757 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...